Drawing for POLYPHOR INNOVATION IN DRUG DISCOVERY

USPTO serial 79051641

POLYPHOR INNOVATION IN DRUG DISCOVERY

Reviewed by CopyMark Law Group

Reg. 3570254Status 709
Filing date
Status date
Registration date
Feb 3, 2009
Examiner
KAUFMAN, LAURIE R
Law office
TMEG LAW OFFICE 103

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with POLYPHOR INNOVATION IN DRUG DISCOVERY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

SCOTT D. WOLDOW

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 Thomas Jefferson St., NWSuite 400WASHINGTON, DC 20007

Goods and services

ClassDescriptionStatusFirst use
001[ Chemicals for use in industry and science; chemical preparations for use in agriculture, namely, chemical preparations for the treatment of seeds; and chemical preparations for use in photography, namely, chemical developers; unprocessed artificial resins as raw materials in the form of powders, liquids or pastes; unprocessed plastics for industrial use; unprocessed plastics in all forms; fertilizers, namely, manures; fire extinguishing compositions; tempering chemicals for use in metalworking or soldering; chemical substances for preserving foodstuffs; tanning agents for use in the manufacture of leather, adhesives for general industrial use ]SECTION 71 - CANCELLED
003[ Bleaching preparations for household use; general purpose cleaning, polishing, scouring and abrasive liquids and powders; soaps; perfumery, essential oils for personal use and for use as ingredients in the manufacture of cosmetic preparations; cosmetics; hair lotions; dentifrices ]SECTION 71 - CANCELLED
005Pharmaceutical anti-allergic preparations and substances, Pharmaceutical for the treatment of erectile dysfunction, Pharmaceutical preparations, namely, anticoagulants, Pharmaceutical preparations, namely, antidepressants, Pharmaceutical preparations, namely, appetite suppressants, Pharmaceutical preparations for use in chemotherapy, Pharmaceutical preparation for the treatment of gout, Pharmaceutical preparations for the treatment of heart rhythm disorders, Pharmaceutical preparations for the treatment of stem cell mobilization, Pharmaceutical preparations for the treatment of infectious diseases, Pharmaceutical preparations acting on the central nervous system, Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, Pharmaceutical preparations for animal skincare, Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, Pharmaceutical preparations for ocular or intraocular surgery, Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations for treating diabetes, Pharmaceutical preparations for treating skin disorders, Pharmaceutical preparations for use in dermatology, Pharmaceutical preparations for wounds, Pharmaceutical preparations for use in urology, Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine, Pharmaceutical products and preparations against dry skin caused by pregnancy, Pharmaceutical products and preparations for chloasma, Pharmaceutical products and preparations for hydrating the skin during pregnancy, Pharmaceutical products and preparations for pregnancy blemishes, Pharmaceutical products and preparations for preventing skin blemishes during pregnancy, Pharmaceutical products and preparations to prevent stretch marks, Pharmaceutical products and preparations to prevent swelling in the legs, Pharmaceutical products for ophthalmological use, Pharmaceutical products for skin care for animals, Pharmaceutical products for the treatment of bone diseases, Pharmaceutical products for the treatment of viral and infectious diseases and for the treatment of cancer, Pharmaceutical products for treating respiratory diseases and asthma, Pharmaceutical skin lotions, Pharmaceutical solutions used in dialysis, Pharmaceuticals, namely, antihelmintics, Pharmaceuticals, namely, inducers of erections, Pharmaceuticals, namely, lipid lowering agents, Pharmaceuticals, namely, psychotropics, Pharmaceuticals, namely, anti-infectives; Veterinary preparations, namely, pain relief medication, veterinary preparations for the treatment of intestinal bacteria, Veterinary vaccine for horses, Veterinary vaccines; sanitary preparations for medical purposes; dietetic foods adapted for medical use, food for babies; medical plasters, dressings for wounds, burns, surgery; dental impression materials; disinfectants for hygienic purposes; preparations for destroying vermin; fungicides and herbicides * all of the aforementioned products exclusively as intermediates for research and test purposes and in form of recipes *SECTION 71 - CANCELLED
042Scientific and technological services in the nature of research in the field of agrochemicals, pharmaceuticals and bio-chemistry and design services relating thereto, namely, scientific and technological services relating to properties of agrochemicals, pharmaceuticals and bio-chemistry; industrial analysis and research services [ ; design and development of computer hardware and software ]SECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 29, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
May 7, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
Jul 10, 2020INNTTOTAL INVALIDATION PROCESSED BY THE IB
Jun 11, 2020INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 11, 2020INPCINVALIDATION PROCESSED
May 6, 2020INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 6, 2019C71TCANCELLED SECTION 71
Dec 3, 2018INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Nov 22, 2018INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 19, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED
Mar 22, 2018COC.CORRECTION UNDER SECTION 7 - PROCESSED
Feb 20, 2018LIMELIMITATION FROM THE IB EXAMINED AND ENTERED
Feb 15, 2018RNWLINTERNATIONAL REGISTRATION RENEWED
Feb 3, 2018REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Nov 24, 2017LIMGLIMITATION OF GOODS RECEIVED FROM IB
Nov 20, 2015INNPPARTIAL INVALIDATION PROCESSED BY THE IB
Oct 14, 2015INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 14, 2015INPCINVALIDATION PROCESSED
Sep 29, 2015INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 29, 2015NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jan 29, 201571.PREGISTERED - PARTIAL SEC 71 ACCEPTED
Jan 29, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 7, 2015ES71TEAS SECTION 71 RECEIVED
May 30, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 18, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB
May 12, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB
May 12, 2009FIMPFINAL DISPOSITION PROCESSED
May 3, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 3, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 18, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 29, 2008NPUBNOTICE OF PUBLICATION
Oct 16, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 16, 2008ALIEASSIGNED TO LIE
Oct 1, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 25, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 25, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 25, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 6, 2008RFNTREFUSAL PROCESSED BY IB
May 16, 2008RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 16, 2008RFRRREFUSAL PROCESSED BY MPU
May 16, 2008RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 15, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2008DOCKASSIGNED TO EXAMINER
Apr 25, 2008NWAPNEW APPLICATION ENTERED
Apr 24, 2008REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance